Hydromorphone hydrochloride 2 MG Oral Tablet — RxCUI 897696
RxNorm drug concept · Semantic clinical drug
RxCUI 897696
Semantic clinical drug · SCD
● Current RxNorm concept 23 FDA products
72 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI897696
Official nameHydromorphone hydrochloride 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asHYDROmorphone HCl 2 MG Oral Tablet
FDA products mapped23
Package NDCs mapped72
Reported Medicaid activity (SDUD)168,596 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hydromorphone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Hydromorphone injection is used to treat severe pain when other pain medicines haven't worked well enough. It's an opioid — a strong prescription pain reliever — and it's typically...
- What is hydromorphone injection used for?
- Common side effects include dizziness, drowsiness, nausea, vomiting, itching, sweating, dry mouth, and constipation — these are typical with opioids. But if your breathing feels ve...
- What side effects should I expect, and which ones mean I need to call for help right away?
🕸️ Concept Web — How Hydromorphone hydrochloride 2 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hydromorphone hydrochloride 2 MG Oral Tablet
RxCUI 897696 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Hydromorphone
3423IN -
Hydromorphone hydrochloride
203177PIN
-
Hydromorphone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Dilaudid
224913BN
-
Dilaudid
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydromorphone Oral Tablet
370654SCDF -
Hydromorphone hydrochloride Oral Tablet
2648247SCDFP -
Hydromorphone Oral Product
1164620SCDG -
Hydromorphone Pill
1164621SCDG -
Hydromorphone hydrochloride Oral Product
2659874SCDGP -
Hydromorphone hydrochloride Pill
2661455SCDGP -
Hydromorphone Oral Tablet [Dilaudid]
368895SBDF -
Hydromorphone hydrochloride Oral Tablet [Dilaudid]
2656942SBDFP - +5 more in this family
-
Hydromorphone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydromorphone hydrochloride 2 MG
897695SCDC -
Hydromorphone hydrochloride 2 MG Oral Tablet [Dilaudid]
897698SBD -
Hydromorphone hydrochloride 2 MG [Dilaudid]
897697SBDC
-
Hydromorphone hydrochloride 2 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydromorphone hydrochloride 2 MG
SCDC · 897695 -
Hydromorphone Oral Tablet
SCDF · 370654 -
Hydromorphone hydrochloride Oral Tablet
SCDFP · 2648247 -
Hydromorphone Oral Product
SCDG · 1164620 -
Hydromorphone Pill
SCDG · 1164621 -
Hydromorphone hydrochloride Oral Product
SCDGP · 2659874 -
Hydromorphone hydrochloride Pill
SCDGP · 2661455
Brand-Name Concepts
-
Hydromorphone hydrochloride 2 MG Oral Tablet [Dilaudid]
SBD · 897698 -
Hydromorphone hydrochloride 2 MG [Dilaudid]
SBDC · 897697 -
Hydromorphone Oral Tablet [Dilaudid]
SBDF · 368895 -
Hydromorphone hydrochloride Oral Tablet [Dilaudid]
SBDFP · 2656942 -
Dilaudid Oral Product
SBDG · 1168870 -
Dilaudid Pill
SBDG · 1168871 -
Dilaudid
BN · 224913
📦 FDA Products & Package NDCs
23 products · 72 package NDCs
72 package NDCs map to RxCUI 897696 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 87063-0037-30 | 30 TABLET in 1 BOTTLE, PLASTIC (87063-037-30) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0037-60 | 60 TABLET in 1 BOTTLE, PLASTIC (87063-037-60) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0037-90 | 90 TABLET in 1 BOTTLE, PLASTIC (87063-037-90) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-01 | 100 TABLET in 1 BOTTLE, PLASTIC (87063-038-01) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-05 | 5 TABLET in 1 BOTTLE, PLASTIC (87063-038-05) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-07 | 7 TABLET in 1 BOTTLE, PLASTIC (87063-038-07) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-10 | 10 TABLET in 1 BOTTLE, PLASTIC (87063-038-10) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-14 | 14 TABLET in 1 BOTTLE, PLASTIC (87063-038-14) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-20 | 20 TABLET in 1 BOTTLE, PLASTIC (87063-038-20) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-30 | 30 TABLET in 1 BOTTLE, PLASTIC (87063-038-30) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-50 | 500 TABLET in 1 BOTTLE, PLASTIC (87063-038-50) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-03 |
| 87063-0038-60 | 60 TABLET in 1 BOTTLE, PLASTIC (87063-038-60) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0038-90 | 90 TABLET in 1 BOTTLE, PLASTIC (87063-038-90) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-01 | 100 TABLET in 1 BOTTLE, PLASTIC (87063-039-01) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-05 | 5 TABLET in 1 BOTTLE, PLASTIC (87063-039-05) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-07 | 7 TABLET in 1 BOTTLE, PLASTIC (87063-039-07) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-10 | 10 TABLET in 1 BOTTLE, PLASTIC (87063-039-10) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-14 | 14 TABLET in 1 BOTTLE, PLASTIC (87063-039-14) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-20 | 20 TABLET in 1 BOTTLE, PLASTIC (87063-039-20) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-30 | 30 TABLET in 1 BOTTLE, PLASTIC (87063-039-30) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-60 | 60 TABLET in 1 BOTTLE, PLASTIC (87063-039-60) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
| 87063-0039-90 | 90 TABLET in 1 BOTTLE, PLASTIC (87063-039-90) | Hydromorphone Hydrochloride | ASCLEMED USA INC. | 2025-12-04 |
Observed labelers:
ASCLEMED USA INC. (28) ·
Aurolife Pharma, LLC (12) ·
Rhodes Pharmaceuticals LLC (12) ·
Bryant Ranch Prepack (9) ·
Ascent Pharmaceuticals Inc (6) ·
SpecGx LLC (3)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.